Features of cerebral venous hemodynamic in patients with hypertensive encephalopathy

Madzhidova E.N.; Yuldasheva M.M.

doi:https://doi.org/10.17116/jnevro202012005137

Madzhidova E.N.

Tashkent Pediatric Medical Institute

Yuldasheva M.M.

Tashkent Pediatric Medical Institute

Features of cerebral venous hemodynamic in patients with hypertensive encephalopathy

Authors:

Madzhidova E.N., Yuldasheva M.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(5): 37‑41

DOI: 10.17116/jnevro202012005137

Read: 4094 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Madzhidova EN, Yuldasheva MM. Features of cerebral venous hemodynamic in patients with hypertensive encephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(5):37‑41. (In Russ.)
https://doi.org/10.17116/jnevro202012005137

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To study the characteristics of main clinical and diagnostic indicators of cerebral venous circulation and their dynamics in patients with hypertensive encephalopathy of various stages treated with cytoflavin.

MATERIAL AND METHODS

Clinical and instrumental data of the examination of 105 patients with the established diagnosis of hypertensive encephalopathy of various stages were analyzed. Cerebral hemodynamics was investigated using transcranial duplex scanning of the veins and sinuses of the brain. Patients (n=85) with diagnostic signs of cerebral venous dysfunction were stratified into two groups by treatment regimen: main group (n=39) received standard antihypertensive therapy with cytoflavin (2 tablets 2 times a day from 1 to 30 days), the control group (n=46) received standard treatment. Control studies of cerebral hemodynamics were performed in both groups on the 30th and 60th day from the start of therapy.

RESULTS AND

Conclusion. The patients who received cytoflavin in the treatment regimen showed a slight improvement on the 30th day and a significant improvement in venous cerebral circulation indicators on the 60th day (p<0,05), which made it possible to conclude that the drug is effective for improving cerebral venous hemodynamics, and to recommend it in the complex therapy of patients with hypertensive encephalopathy of various stages with existing venous cerebral disorders.

Keywords:

hypertensive encephalopathy

cerebral venous circulation

cytoflavin

Authors:

Madzhidova E.N.

Tashkent Pediatric Medical Institute

Yuldasheva M.M.

Tashkent Pediatric Medical Institute

Received:

09.01.2020

Accepted:

11.03.2020

Close metadata

References:

Belova LA. Venous cerebral discirculation at chronic cerebral ischemia: clinics, diagnostics, treatment Neurological bulletin. 2010;XLII:2:62-67. (In Russ.).
Vasilyev IA, Stupak VV, Chernykh VA, Polovnikov EV, Chernykh ER, Shevela EYa, Dergilev AP. Pathogenetic aspects of cerebral venous circulation disorder International journal of applied and fundamental research. 2014;9-3:23-26 (In Russ.).
Manvelov LS, Kadykov AV. Venous insufficiency of brain circulation Atmosfera. Nervnye bolezni. 2007;2:18-21 (In Russ.).
Gafurov BG, Alikulova NA, Nazarova ZhA. Clinical and functional features of the venous cerebral circulation in chronic brain ischemia. Neurology Journal. 2018;4:45-48. (In Russ.).
Semenov SE, Shumilina MV, Zhuchkova EA, Semenov AS. Diagnostic of the cerebral venous ischemia Klinicheskaya fiziologiya krovoobrashcheniya. 2015;2:5-16. (In Russ.).
Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood. Nature. 2010 Nov 11;468(7321):232-243. https://doi.org/10.1038/nature09613
Shumilina MV. Complex ultrasound diagnosis of disorders of the venous outflow. Klinicheskaya fiziologiya krovoobrashcheniya. 2009;3:21-29. (In Russ.).
Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D. Cerebral blood flow response to functional activation. Journal of Cerebral Blood Flow & Metabolism. 2010 Jan;30(1):2-14. https://doi.org/10.1038/jcbfm.2009.188
Mishchenko TS, Zdesenko IV, Mishchenko VN. Therapeutic options for the treatment of cerebral venous disorders. Mezhdunarodnyj nevrologicheskij zhurnal. 2011;1:39. (In Russ.).
Belova LA, Mashin VV, Nikitin YuM, Belov VG. Hypertensive encephalopathy: clinical and pathogenetic subtypes, classification, diagnosis. Ul’yanovsk.: UlGU, 2010;204. (In Russ.).
Zueva IB, Krivonosov DS, Buch AV, Kim YuV. Possibilities of treating cognitive impairment in patients with metabolic syndrome. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018;5:36-40. (In Russ.). https://doi.org/10.17116/jnevro20181185118
Belova LA, Mashin VV, Kolotik-Kameneva OYu, Belova NV, Anzhelo Skuderi, P’er Luidzhi Antignani. The effect of therapy with Cytoflavin on structural and functional remodeling of cerebral vessels at various stages of hypertension. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2017;7:28-35. (In Russ.). https://doi.org/10.17116/jnevro20171177128-35